{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:56:49Z","timestamp":1793811409880,"version":"4.6.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xphs.2025.104139","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T07:56:03Z","timestamp":1766562963000},"page":"104139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dermal disposition characterization and development of a retrospective level A in vitro\u2013in vivo relationship for topical metronidazole products"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9900-8912","authenticated-orcid":false,"given":"Benjamin A.","family":"Kuzma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Senemar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Ramezanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam G.","family":"Raney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Stagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.104139_bib0001","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1208\/s12248-013-9472-8","article-title":"Generic development of topical dermatologic products, Part II: quality by design for topical semisolid products","volume":"15","author":"Chang","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104139_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1208\/s12248-012-9411-0","article-title":"Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products","volume":"15","author":"Chang","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104139_bib0003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11095-013-1259-1","article-title":"Current challenges in bioequivalence, quality, and novel assessment technologies for topical products","volume":"31","author":"Yacobi","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-020-02821-z","article-title":"Cutaneous pharmacokinetics of acyclovir cream 5% products: evaluating bioequivalence with an in vitro permeation test and an adaptation of scaled average bioequivalence","volume":"37","author":"Shin","year":"2020","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11095-016-1960-y","article-title":"Kinetics of clobetasol-17-propionate in psoriatic lesional and non-lesional skin assessed by dermal open flow microperfusion with time and space resolution","volume":"33","author":"Bodenlenz","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01312266","article-title":"Linear systems analysis in pharmacokinetics","volume":"6","author":"Cutler","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.xphs.2025.104139_bib0007","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jps.2600531126","article-title":"Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug","volume":"53","author":"Wagner","year":"1964","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0008","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jps.2600570602","article-title":"New method for calculating the intrinsic absorption rate of drugs","volume":"57","author":"Loo","year":"1968","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01312264","article-title":"Numerical deconvolution by least squares: use of prescribed input functions","volume":"6","author":"Cutler","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.xphs.2025.104139_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1208\/s12248-015-9849-y","article-title":"Deconvolution and IVIVC: exploring the role of rate-limiting conditions","volume":"18","author":"Margolskee","year":"2016","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104139_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT070300P6","article-title":"IVIVR versus IVIVC","volume":"7","author":"Polli","year":"2000","journal-title":"Dissolut Technol"},{"key":"10.1016\/j.xphs.2025.104139_bib0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2015.05.263","article-title":"Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems","volume":"210","author":"Yang","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.104139_bib0013","series-title":"Drug Delivery Approaches","first-page":"241","article-title":"Topical delivery: toward an IVIVC","author":"Raney","year":"2021"},{"key":"10.1016\/j.xphs.2025.104139_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.02.029","article-title":"A survey on IVIVC\/IVIVR development in the pharmaceutical industry-past experience and current perspectives","volume":"102","author":"Nguyen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0015","series-title":"In Vitro-in Vivo Correlations","first-page":"269","article-title":"Draft guidance for industry extended-release solid oral dosage forms: development, evaluation and application of in vitro-in vivo correlations","author":"Malinowski","year":"1997"},{"issue":"4","key":"10.1016\/j.xphs.2025.104139_bib0016","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11095-017-2099-1","article-title":"Bioequivalence methodologies for topical drug products: in vitro and ex vivo studies with a corticosteroid and an anti-fungal drug","volume":"34","author":"Leal","year":"2017","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.104139_bib0017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40262-016-0442-z","article-title":"Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence","volume":"56","author":"Bodenlenz","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2025.104139_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2020.03.003","article-title":"Imaging and quantifying drug delivery in skin - part 2: fluorescence andvibrational spectroscopic imaging methods","volume":"153","author":"Pena","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.104139_bib0019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jid.2020.06.027","article-title":"Label-free quantification of pharmacokinetics in skin with stimulated Raman scattering microscopy and deep learning","volume":"141","author":"Feizpour","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.xphs.2025.104139_bib0020","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1364\/BOE.432177","article-title":"Multi-window sparse spectral sampling stimulated Raman scattering microscopy","volume":"12","author":"Pence","year":"2021","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.xphs.2025.104139_bib0021","first-page":"12","article-title":"Franz cell diffusion testing and quantitative confocal Raman spectroscopy: in vitro-in vivo correlation","author":"Iliopoulos","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104139_bib0022","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jconrel.2024.02.010","article-title":"Determining topical product bioequivalence with stimulated Raman scattering microscopy","volume":"367","author":"Iliopoulos","year":"2024","journal-title":"J Controlled Release"},{"issue":"3","key":"10.1016\/j.xphs.2025.104139_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1773-2247(14)50044-5","article-title":"Applications of dermal microdialysis: a review","volume":"24","author":"Shukla","year":"2014","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2025.104139_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105741","article-title":"Evaluation of local bioavailability of metronidazole from topical formulations using dermal microdialysis: preliminary study in a Yucatan Mini-Pig Model","volume":"159","author":"Kuzma","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpb.2022.05.001","article-title":"The dose-duration effect on cutaneous pharmacokinetics of metronidazole from topical dermatological formulations in Yucatan Mini-Pigs","volume":"175","author":"Kuzma","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.104139_bib0026","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0165-0270(93)90096-A","article-title":"A survey on quantitative microdialysis: theoretical models and practical implications","volume":"48","author":"Kehr","year":"1993","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.xphs.2025.104139_bib0027","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","author":"Chaurasia","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0028","series-title":"Clinical Pharmacokinetics\/Pharmacodynamics","author":"Rowland","year":"2005"},{"key":"10.1016\/j.xphs.2025.104139_bib0029","series-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","author":"Gabrielsson","year":"2001"},{"key":"10.1016\/j.xphs.2025.104139_bib0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jps.2600690314","article-title":"Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response i: theoretical analysis","volume":"69","author":"Pedersen","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0031","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0169-409X(01)00119-3","article-title":"Noncompartmentally-based pharmacokinetic modeling","volume":"48","author":"Veng-Pedersen","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.104139_bib0032","series-title":"AAPS Annual Meeting. San Diego, CA","article-title":"Correlation between the quality attributes and performance characteristics of metronidazole gels and creams: implications for the evaluation of bioequivalence","author":"Rangappa","year":"2017"},{"key":"10.1016\/j.xphs.2025.104139_bib0033","series-title":"Characterizing the Critical Quality Attributes and In Vitro Bioavailability of Acyclovir and Metronidazole Topical Products","author":"Murthy","year":"2019"},{"key":"10.1016\/j.xphs.2025.104139_bib0034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1208\/s12248-018-0250-5","article-title":"Time scaling for in vitro-in vivo correlation: the inverse release function (IRF) approach","volume":"20","author":"Cardot","year":"2018","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104139_bib0035","series-title":"RStudio: Integrated Development Environment for R","author":"RStudio Team","year":"2020"},{"key":"10.1016\/j.xphs.2025.104139_bib0036","first-page":"S46","article-title":"Dermal clearance, elimination half-life, and apparent volume of distribution of lidocaine and prilocaine are independent of the dose delivered directly in dermis using a dermal infusion technique","volume":"111","author":"Senemar","year":"2022","journal-title":"Clinic Pharmacol Therap"},{"key":"10.1016\/j.xphs.2025.104139_bib0037","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1023\/A:1020753329492","article-title":"Transdermal drug delivery by jet injectors: energetics of jet formation and penetration","volume":"19","author":"Schramm","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0038","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12248-021-00571-3","article-title":"Assessment of drug delivery kinetics to epidermal targets in vivo","volume":"23","author":"Hoppel","year":"2021","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.xphs.2025.104139_bib0039","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13346-021-01064-8","article-title":"Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling","volume":"12","author":"Pensado","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.104139_bib0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13346-020-00864-8","article-title":"Predicting topical drug clearance from the skin","volume":"11","author":"Maciel Tabosa","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2025.104139_bib0041","series-title":"Investigation of Percutaneous Drug Pharmacokinetics in Yucatan Mini-Pig Utilizing Microdialysis: Development of an In Vitro-In-Vivo Relationship with Metronidazole Topical Dermatological Drug Products","author":"Kuzma","year":"2020"},{"key":"10.1016\/j.xphs.2025.104139_bib0042","series-title":"LC-MS\/MS Method for the Quantification of Metronidazole in Skin Dialysate","author":"Kuzma","year":"2018"},{"key":"10.1016\/j.xphs.2025.104139_bib0043","series-title":"Bioanalytical Method Validation and Study Sample Analysis M10","author":"Guideline","year":"2022"},{"key":"10.1016\/j.xphs.2025.104139_bib0044","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/pch\/16.9.535","article-title":"Pharmacokinetics 101","volume":"16","author":"Ito","year":"2011","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.xphs.2025.104139_bib0045","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/jps.23106","article-title":"Dermal clearance model for epidermal bioavailability calculations","volume":"101","author":"Ibrahim","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0046","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1288\/00005537-199504000-00009","article-title":"Comparison of laser doppler flowmeter and radioactive microspheres in measuring blood flow in pig skin flaps","volume":"105","author":"Rival","year":"1995","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.xphs.2025.104139_bib0047","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)91036-4","article-title":"Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion","volume":"328","author":"Lee Sendelbeck","year":"1985","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.104139_bib0048","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0169-409X(98)00089-1","article-title":"Microdialysis for pharmacokinetic analysis of drug transport to the brain","volume":"36","author":"de Lange","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.104139_bib0049","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0625.2007.00636.x","article-title":"Skin research and drug localization with receptor microscopic autoradiography","volume":"17","author":"Stumpf","year":"2008","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104139_bib0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/mp200122w","article-title":"Imaging drug delivery to skin with stimulated Raman scattering microscopy","volume":"8","author":"Saar","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2025.104139_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100151","article-title":"Instantaneous topical drug quantification using a 3d printed microfluidic device and coherent Raman imaging","author":"Kuzma","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.xphs.2025.104139_bib0052","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1002\/pmic.200600938","article-title":"Suction blister fluid as potential body fluid for biomarker proteins","volume":"7","author":"Kool","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.xphs.2025.104139_bib0053","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s42003-018-0170-z","article-title":"Extraction and biomolecular analysis of dermal interstitial fluid collected with hollow microneedles","volume":"1","author":"Miller","year":"2018","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.xphs.2025.104139_bib0054","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41551-022-00998-9","article-title":"Opportunities and challenges in the diagnostic utility of dermal interstitial fluid","volume":"7","author":"Friedel","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.xphs.2025.104139_bib0055","doi-asserted-by":"crossref","unstructured":"Adamczak J, Raml R, Wollner O, Sinner F, Birngruber T. Investigation of protein binding in skin with dermal open flow microperfusion (dOFM). J Investig Dermatol 137, S201.","DOI":"10.1016\/j.jid.2017.07.145"},{"key":"10.1016\/j.xphs.2025.104139_bib0056","article-title":"OFM-recirculation and OFM-suction: advanced in-vivo open flow microperfusion (OFM) methods for direct and absolute quantification of albumin in interstitial fluid","volume":"6","author":"Hummer","year":"2021","journal-title":"Biomed Phys Eng Express"},{"key":"10.1016\/j.xphs.2025.104139_bib0057","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1124\/dmd.108.021915","article-title":"Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application","volume":"36","author":"Weiss","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2025.104139_bib0058","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jps.2600710728","article-title":"Effect of skin binding on percutaneous transport of benzocaine from aqueous suspensions and solutions","volume":"71","author":"Dalvi","year":"1982","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104139_bib0059","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2017.11.034","article-title":"In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application","volume":"270","author":"Shin","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.104139_bib0060","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s11095-017-2247-7","article-title":"Utility of gottingen minipigs for prediction of human pharmacokinetic profiles after dermal drug application","volume":"34","author":"Yamamoto","year":"2017","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.104139_bib0061","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/pharmaceutics15010268","article-title":"In vitro-in vivo correlations (IVIVC) for predicting the clinical performance of metronidazole topical creams intended for local action","volume":"15","author":"Rath","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104139_bib0062","series-title":"Guidance For Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of in Vitro\/in Vivo Correlations","year":"1997"},{"key":"10.1016\/j.xphs.2025.104139_bib0063","series-title":"The Minipig in Biomedical Research","author":"McAnulty","year":"2012"},{"key":"10.1016\/j.xphs.2025.104139_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123269","article-title":"Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo open flow microperfusion","volume":"643","author":"Schwagerle","year":"2023","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:39Z","timestamp":1786649259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022354925005933"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104139","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermal disposition characterization and development of a retrospective level A in vitro\u2013in vivo relationship for topical metronidazole products","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104139"}}